Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-06

Clinical Trial Update: Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing the efficacy and safety of tofacitinib in psoriatic arthritis; results from the comparator study were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-07-06